Gender-specific association between pulse pressure and C-reactive protein in a Chinese population

Journal of Human Hypertension

Volumn 19, Issue 4, 2005, Pages 293-299

  Li, X ^a   Zhang, J ^a   Huang, J ^a   Xie, S ^b   Zhu, J ^b   Jiang, S ^a   Li, Y ^c   Wang, Ji Guang ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Taicang 2nd Hospital   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; C reactive protein; Chinese; Gender; Menopause; Pulse pressure

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LATEX; RESERPINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CAROTID ARTERY DISEASE; CHINESE; CLINICAL OBSERVATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; NEPHELOMETRY; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE PRESSURE; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; URBAN POPULATION;

EID: 17144430415     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001818     Document Type: Article

References (31)

1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
2. Franklin SS et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-315.
3. Blacher J et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160: 1085-1089.
4. Sesso HD et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 2000; 36: 801-807.
5. Benetos A et al. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 2001; 35: 672-680.
6. Kostis JB et al. Association of increased pulse pressure with the development of heart failure in SHEP. Am J Hypertens 2001; 14: 798-803.
7. Domanski M et al. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 2001; 38: 793-797.
8. Staessen J, Amery A, Fagard R. Editorial review. Isolated systolic hypertension in the elderly. J Hypertens 1990; 8: 393-405.
9. Franklin SS et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37: 869-874.
10. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869.
11. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
12. Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens 2003; 17: 223-230.
13. Di Napoli M, Papa F. Association between blood pressure and C-reactive protein levels in acute ischemic stroke. Hypertension 2003; 42: 1117-1123.
14. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002; 39: 197-202.
15. Schillaci G et al. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 2003; 21: 1841-1846.
16. Sung KC et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003; 16: 429-433.
17. Bautista LE et al. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: 857-861.
18. Sesso HD et al. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945-2951.
19. Zanchetti A et al. Systolic and pulse pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. J Hypertens 2001; 19: 79-88.
20. Wang TJ et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002; 22: 1662-1667.
21. Praetorius E. Enzymatic method for determination of uric acid by ultraviolet spectrophotometry. Scand J Clin Lab Invest 1949; 1: 222-230.
22. Amar J et al. Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. J Hypertens 2004; 22: 349-355.
23. Yamada S et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001; 153: 1183-1190.
24. Dreon DM, Slavin JL, Phinney SD. Oral contraceptive use and increased plasma concentration of C-reactive protein. Life Sci 2003; 73: 1245-1252.
25. Kluft C, Leuven JA, Helmerhorst FM, Krans HM. Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascul Pharmacol 2002; 39: 149-154.
26. Oelkers W et al. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 1995; 80: 1816-1821.
27. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
28. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
29. Ridker PM et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
30. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003; 108 1053-1058.
31. Alberti KGMM, Zimmer PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15 539-553.